Fibroblast Growth Factors 19 and 21 in Gestational Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2016

Conditions
Gestational Diabetes Mellitus
Interventions
DIAGNOSTIC_TEST

biachemical detection

"Serum FGF19 and FGF21 levels were determined by enzyme-linked immunosorbent assay (ELISA) and were correlated with anthropometric, metabolic, and endocrine parameters. Homeostasis model assessment (HOMA-IR) index was calculated and analysed.~Second, samples for measurement were obtained from 30 women with GDM and 35 healthy pregnant controls undergoing caesarean sections at term. mRNA and protein expression levels of FGF19/FGF21 and their co-receptor βKlotho(KLB)in placenta, rectus muscle and subcutaneous fat tissues were investigated with real-time quantitative polymerase chain reaction (qRT-PCR), western-blot and immunohistochemistry (IHC), respectively. Clinical data were collected and analysed."

Trial Locations (1)

510080

Obstetrics and Gynechology Department of the 1st affiliated hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

First Affiliated Hospital, Sun Yat-Sen University

OTHER

NCT01858597 - Fibroblast Growth Factors 19 and 21 in Gestational Diabetes Mellitus | Biotech Hunter | Biotech Hunter